Björn Dahlbäck Selected Research

Factor V (Coagulation Factor V)

5/2016	Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
9/2013	Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.
7/2013	Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation.
7/2008	Advances in understanding pathogenic mechanisms of thrombophilic disorders.
9/2007	Coagulation factor V and thrombophilia: background and mechanisms.
5/2004	Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.
8/2003	Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.
5/2003	Factor V Leiden in pregnancies complicated by placental abruption.
2/2003	Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states.
2/2003	Congenital and acquired activated protein C resistance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Björn Dahlbäck Research Topics

Disease

19	Thrombosis (Thrombus) 01/2021 - 05/2002
11	Activated Protein C Resistance (APC Resistance) 05/2016 - 05/2002
9	Neoplasms (Cancer) 01/2022 - 12/2002
9	Atherosclerosis 08/2015 - 06/2006
8	Venous Thrombosis (Deep-Vein Thrombosis) 03/2018 - 12/2002
8	Hemorrhage 05/2016 - 04/2002
6	Inflammation (Inflammations) 01/2020 - 04/2008
5	Thrombophilia 01/2022 - 08/2002
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2015 - 01/2009
3	Venous Thromboembolism 04/2018 - 03/2014
3	Coronary Disease (Coronary Heart Disease) 07/2016 - 09/2008
3	Sepsis (Septicemia) 01/2016 - 01/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 04/2011
2	Protein S Deficiency (Deficiency, Protein S) 03/2018 - 12/2002
2	Alzheimer Disease (Alzheimer's Disease) 06/2017 - 07/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 03/2009
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2009
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2012 - 01/2010
2	Abdominal Aortic Aneurysm 03/2010 - 01/2010
2	Carcinogenesis 01/2009 - 12/2006
2	Factor V Deficiency 08/2003 - 10/2002
1	Genetic Risk Score 01/2020
1	Heart Failure 01/2020
1	Leukopenia 01/2019
1	Albuminuria 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2018
1	Chronic Renal Insufficiency 02/2018
1	Hemophilia A (Haemophilia) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Asthma (Bronchial Asthma) 10/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Vascular Diseases (Vascular Disease) 08/2015
1	Amyloidosis 07/2012
1	Lupus Nephritis 04/2011
1	Nephritis 04/2011
1	Type 2 Diabetes Mellitus (MODY) 11/2010
1	Diabetes Mellitus 11/2010

Drug/Important Bio-Agent (IBA)

17	Apolipoproteins MIBA 01/2020 - 06/2006
16	Protein CIBA 01/2022 - 02/2003
14	AnticoagulantsIBA 01/2022 - 12/2002
13	factor V LeidenIBA 01/2022 - 05/2002
11	Factor V (Coagulation Factor V)IBA 05/2016 - 10/2002
10	Protein SIBA 01/2022 - 12/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
6	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 07/2009
5	HDL LipoproteinsIBA 02/2018 - 06/2006
5	Messenger RNA (mRNA)IBA 01/2016 - 11/2005
5	ApolipoproteinsIBA 12/2012 - 06/2006
4	Prothrombin (Factor II)IBA 01/2022 - 07/2008
4	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 02/2018 - 08/2015
4	CholesterolIBA 07/2016 - 01/2008
4	growth arrest-specific protein 6IBA 06/2011 - 01/2010
3	AntithrombinsIBA 01/2022 - 01/2020
3	HDL CholesterolIBA 02/2018 - 05/2010
3	oxidized low density lipoproteinIBA 03/2012 - 05/2010
2	EnzymesIBA 01/2020 - 01/2010
2	ImmunosorbentsIBA 01/2020 - 01/2010
2	Biological ProductsIBA 01/2020 - 01/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 11/2010
2	Triglycerides (Triacylglycerol)IBA 02/2018 - 01/2018
2	Axl Receptor Tyrosine KinaseIBA 10/2017 - 12/2002
2	Protein Isoforms (Isoforms)IBA 05/2016 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2010
2	LipidsIBA 01/2016 - 08/2009
2	Apolipoproteins E (ApoE)IBA 08/2015 - 05/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 12/2012 - 05/2010
2	Thrombin FDA Link 07/2012 - 04/2002
2	Apolipoproteins AIBA 04/2010 - 03/2010
2	TensinsIBA 01/2010 - 01/2009
2	LigandsIBA 07/2009 - 12/2006
2	LDL Receptors (LDL Receptor)IBA 01/2008 - 06/2006
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2020
1	Liver X ReceptorsIBA 01/2020
1	Mineralocorticoid Receptor AntagonistsIBA 01/2020
1	anti-dsDNA autoantibodyIBA 01/2019
1	AlbuminsIBA 02/2018
1	CytokinesIBA 02/2018
1	lipoprotein cholesterolIBA 06/2017
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 05/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2015
1	methylallyl trisulfide (MATS)IBA 03/2014
1	LDL CholesterolIBA 12/2012
1	Apolipoproteins B (ApoB)IBA 12/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2012
1	polyethylene glycol polyethyleneimine nanogelIBA 07/2012
1	Peptides (Polypeptides)IBA 07/2012
1	Amyloid (Amyloid Fibrils)IBA 07/2012
1	thioflavin TIBA 07/2012
1	MannansIBA 07/2012
1	Complement C4b-Binding ProteinIBA 06/2011
1	Antinuclear AntibodiesIBA 04/2011
1	Fibric Acids (Fibrates)IBA 11/2010
1	Lipoproteins (Lipoprotein)IBA 05/2010

Therapy/Procedure

2	Therapeutics 01/2009 - 04/2003
1	Renal Dialysis (Hemodialysis) 07/2012